Evidence map›Paper›PMID 31455256›Full record

ArticleBMC infectious diseases2019

Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012-2017: a secondary dataset analysis.

Marvellous Mhondoro, Nqobile Ndlovu, Donewell Bangure, Tsitsi Juru, Notion Tafara Gombe, Gerald Shambira, Peter Nsubuga, Mufuta Tshimanga

Abstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Antimicrobial resistance trends in clinicalAfrican journal of laboratory medicine · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marvellous MhondoroDepartment of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Nqobile NdlovuAfrican Society of Laboratory Medicine, Addis Ababa, Ethiopia. nqndlovu@yahoo.com.
Donewell BangureAfrica Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.
Tsitsi JuruDepartment of Community Medicine, University of Zimbabwe, Harare, Zimbabwe. tsitsijuru@gmail.com.ORCID http://orcid.org/0000-0002-3570-2331
Notion Tafara GombeDepartment of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Gerald ShambiraDepartment of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
Peter NsubugaGlobal Health Solutions, Atlanta, GA, USA.
Mufuta TshimangaDepartment of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance is one of the most serious public health threats of the twenty-first century. The implementation of AMR surveillance in Zimbabwe is limited. However, data from a private laboratory in Harare revealed increasing resistance rates to common antibiotics like ampicillin (i.e., from 73.9% in 2011 to 74.6% in 2015). The increasing resistance rates indicate that Zimbabwe is affected by AMR. This study was done to determine the magnitude of AMR in Harare and determine the trends of AMR to first-line and to last-resort antibiotics and make recommendations to mitigate the problem.

methodsA retrospective record review of data collected from the microbiology department at a private laboratory between January 2012 and December 2017 was done. The outcome of interest was the antibiotic susceptibility of bacterial isolates. Microsoft Excel 2016 was used to plot trends from 2012 to 2017 and Epi Info™7 was used for statistical analysis.

resultsA total of 23,432 isolates, of 12 medically important bacteria were analysed. Forty-three percent of the isolates were from urines, 36.7% were from pus swabs and 7% were from blood. The most common pathogen was Escherichia coli (43.2%), followed by Staphylococcus aureus (15.8%) and the least common was Neisseria gonorrhoea (0.2%). Resistance was highest to ampicillin followed by penicillin, both ranging between 70 and 100% over the six years. Statistically significant increases in resistance to commonly used antibiotics were observed in amoxicillin-resistant E. coli and Streptococcus pneumonia and third generation cephalosporin-resistant E. coli. There was an increase in resistance to last-line antibiotics i.e., fluoroquinolone-resistant Salmonella spp. and carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. However, methicillin-resistant S. aureus showed a decreasing trend.

conclusionsThere is a high burden of drug resistance to common antibiotics in Harare and an emergence of resistance to last-line antibiotics.

Indexed as

Acinetobacter baumanniiAmpicillinAnti-Bacterial AgentsBacteriaBacterial InfectionsCephalosporinsDrug Resistance, BacterialEscherichia coliHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPseudomonas aeruginosaRetrospective StudiesStaphylococcus aureusZimbabweAmpicillinAnti-Bacterial AgentsCephalosporinsAntibioticAntimicrobial agentsResistance

Identifiers

PMID31455256
PMCPMC6712611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.